CD274 and cancer: Along with the growing interest in immune checkpoint inhibitors in cancer treatment, many investigations in the field of radiotherapy have focused on programmed death‐ligand 1 (PD‐L1) protein which plays an important role for cancer cells to escape immune surveillance.3